Suppression of Wnt/β-catenin signaling via Kras/ERK/Foxm1 activation results in accumulation of atypical SOX9+ BC in the proximal airways and subsequent disruption of normal morphogenesis [43]. This evidence concerns the gene KRAS and breast cancer.